Your browser doesn't support javascript.
loading
LUNGBANK: a novel biorepository strategy tailored for comprehensive multiomics analysis and P-medicine applications in lung cancer.
Demircan Çeker, Dilek; Baysungur, Volkan; Evman, Serdar; Kolbas, Ilker; Gördebil, Abdurrahim; Nalbantoglu, Sinem M; Tambag, Yusuf; Kaçar, Ömer; Midi, Ahmet; Aslanoglu, Hatice; Kara, Nülüfer; Algan, Nilgün; Boyacioglu, Ayberk; Karademir Yilmaz, Betül; Sahin, Ali; Ülbegi Polat, Hivda; Sehitogullari, Abidin; Çibikdiken, Ali Osman; Büyükyilmaz, Mücahit; Aydilek, Ibrahim Berkan; Enes, Abdulkerim; Küçüker, Sevde; Karakaya, Fatih; Boyaci, Ihsan; Gümüs, Mahmut; Senol, Onur; Öztug, Merve; Saban, Evren; Soysal, Ömer; Büyükpinarbasili, Nur; Turna, Akif; Günlüoglu, Mehmet Zeki; Çakir, Asli; Tekin, Saban; Tazebay, Uygar; Karadag, Abdullah.
Afiliação
  • Demircan Çeker D; Molecular Oncology Laboratory, Medical Biotechnology Research Group, VPLS, TÜBITAK Marmara Research Center, Kocaeli, Turkiye.
  • Baysungur V; Department of Molecular Biology and Genetics, Gebze Technical University, Kocaeli, Turkiye.
  • Evman S; Department of Thoracic Surgery, Faculty of Medicine, University of Health Sciences, Istanbul, Turkiye.
  • Kolbas I; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Gördebil A; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Nalbantoglu SM; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Tambag Y; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Kaçar Ö; Molecular Oncology Laboratory, Medical Biotechnology Research Group, VPLS, TÜBITAK Marmara Research Center, Kocaeli, Turkiye.
  • Midi A; Software Technologies Research Institute, TÜBITAK Informatics and Information Security Research Center, Ankara, Turkiye.
  • Aslanoglu H; Molecular Oncology Laboratory, Medical Biotechnology Research Group, VPLS, TÜBITAK Marmara Research Center, Kocaeli, Turkiye.
  • Kara N; Department of Pathology, Faculty of Medicine, Bahçesehir University, Istanbul, Turkiye.
  • Algan N; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Boyacioglu A; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Karademir Yilmaz B; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Sahin A; Department of Thoracic Surgery, Süreyyapasa Training and Research Hospital, Istanbul, Turkiye.
  • Ülbegi Polat H; Division of Biochemistry, Department of Basic Medical Sciences, Faculty of Medicine, Marmara University, Istanbul, Turkiye.
  • Sehitogullari A; Genetic and Metabolic Diseases Research and Investigation Center (GEMHAM), Marmara University, Istanbul, Turkiye.
  • Çibikdiken AO; Division of Biochemistry, Department of Basic Medical Sciences, Faculty of Medicine, Marmara University, Istanbul, Turkiye.
  • Büyükyilmaz M; Genetic and Metabolic Diseases Research and Investigation Center (GEMHAM), Marmara University, Istanbul, Turkiye.
  • Aydilek IB; Molecular Oncology Laboratory, Medical Biotechnology Research Group, VPLS, TÜBITAK Marmara Research Center, Kocaeli, Turkiye.
  • Enes A; Department of Thoracic Surgery, Faculty of Medicine, Sakarya University, Sakarya, Turkiye.
  • Küçüker S; Department of Computer Sciences and Engineering, KTO Karatay University, Konya, Turkiye.
  • Karakaya F; Ecolarium Digital Technologies Inc., Istanbul, Turkiye.
  • Boyaci I; Department of Computer Engineering, Faculty of Engineering, Harran University, Sanliurfa, Turkiye.
  • Gümüs M; Department of Computer Engineering, Faculty of Engineering, Harran University, Sanliurfa, Turkiye.
  • Senol O; Molecular Oncology Laboratory, Medical Biotechnology Research Group, VPLS, TÜBITAK Marmara Research Center, Kocaeli, Turkiye.
  • Öztug M; Molecular Oncology Laboratory, Medical Biotechnology Research Group, VPLS, TÜBITAK Marmara Research Center, Kocaeli, Turkiye.
  • Saban E; Department of Internal Medicine, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkiye.
  • Soysal Ö; Department of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkiye.
  • Büyükpinarbasili N; Department of Analytical Chemistry, Faculty of Pharmacy, Atatürk University, Erzurum, Turkiye.
  • Turna A; TÜBITAK National Metrology Institute, Kocaeli, Turkiye.
  • Günlüoglu MZ; TÜBITAK National Metrology Institute, Kocaeli, Turkiye.
  • Çakir A; Department of Thoracic Surgery, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.
  • Tekin S; Department of Pathology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.
  • Tazebay U; Department of Thoracic Surgery, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye.
  • Karadag A; Department of Thoracic Surgery, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkiye.
Turk J Biol ; 48(3): 203-217, 2024.
Article em En | MEDLINE | ID: mdl-39050710
ABSTRACT
Background/

aim:

LUNGBANK was established as part of Project LUNGMARK, pioneering a biorepository dedicated exclusively to lung cancer research. It employs cutting-edge technologies to streamline the handling of biospecimens, ensuring the acquisition of high-quality samples. This infrastructure is fortified with robust data management capabilities, enabling seamless integration of diverse datasets. LUNGBANK functions not merely as a repository but as a sophisticated platform crucial for advancing lung cancer research, poised to facilitate significant discoveries. Materials and

methods:

LUNGBANK was meticulously designed to optimize every stage of biospecimen handling, from collection and storage to processing. Rigorous standard operating procedures and stringent quality control measures guarantee the integrity of collected biospecimens. Advanced data management protocols facilitate the efficient integration and analysis of various datasets, enhancing the depth and breadth of research possibilities in lung cancer.

Results:

LUNGBANK has amassed a comprehensive collection of biospecimens essential for unraveling the intricate molecular mechanisms of lung cancer. The integration of state-of-the-art technologies ensures the acquisition of top-tier data, fostering breakthroughs in translational and histological research. Moreover, the establishment of patient-derived systems by LUNGBANK underscores its pivotal role in personalized medicine approaches.

Conclusion:

The establishment of LUNGBANK marks a significant milestone in addressing the critical challenges of lung cancer research. By providing researchers with high-quality biospecimens and advanced research tools, LUNGBANK not only supports Project LUNGMARK's objectives but also contributes extensively to the broader landscape of personalized medicine. It promises to enhance our understanding of lung cancer initiation, progression, and therapeutic interventions tailored to individual patient needs, thereby advancing the field towards more effective diagnostic and therapeutic strategies.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Turk J Biol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Turk J Biol Ano de publicação: 2024 Tipo de documento: Article